You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 15, April 20, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Women's Health, Other
 •Alert me on articles by topic

Urinary Placental Growth Factor and Preeclampsia—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Carbillon and Uzan raise the question of whether concentrations of PlGF might be used to distinguish pregnancies with growth-retarded fetuses due to uteroplacental insufficiency from those with constitutionally small fetuses. While this is an important question, the Calcium for Preeclampsia Prevention trial did not include uterine artery Doppler ultrasonography data, so we were unable to make this distinction.

In our main study, urinary PlGF in the lowest quartile of the distribution of specimens obtained at 21 to 32 weeks of gestation from women who remained normotensive throughout pregnancy was strongly associated with the subsequent development of preeclampsia before 37 weeks. Low PlGF at 21 to 32 weeks was associated with an odds ratio for preeclampsia before 37 weeks that was 14-fold greater than that for preeclampsia occurring at later gestational age, regardless of the presence or absence of an SGA infant (odds ratios for the lowest vs . . . [Full Text of this Article]

Richard J. Levine, MD
Division of Epidemiology, Statistics, and Prevention Research
National Institute of Child Health and Human Development
Bethesda, Md

Franklin H. Epstein, MD
Division of Nephrology
Department of Medicine

S. Ananth Karumanchi, MD
sananth@bidmc.harvard.edu
Division of Nephrology
Departments of Medicine, Obstetrics, and Gynecology
Beth Israel Deaconess Medical Center
Boston, Mass


RELATED ARTICLES

Urinary Placental Growth Factor and Preeclampsia
Lionel Carbillon and Michele Uzan
JAMA. 2005;293(15):1857.
EXTRACT | FULL TEXT  

Urinary Placental Growth Factor and Risk of Preeclampsia
Richard J. Levine, Ravi Thadhani, Cong Qian, Chun Lam, Kee-Hak Lim, Kai F. Yu, Anastasia L. Blink, Benjamin P. Sachs, Franklin H. Epstein, Baha M. Sibai, Vikas P. Sukhatme, and S. Ananth Karumanchi
JAMA. 2005;293(1):77-85.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.